SILO PHARMA INC.(SILO)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

SILO SILO PHARMA INC.

盘后交易 06-09 17:29:06 EDT

6.46

+0.20

+3.19%

盘后6.61

+0.15+2.30%

17:23 EDT

最高6.70	最低6.12	成交量1.86万
今开6.21	昨收6.26	日振幅9.27%
总市值700.55万	流通市值681.87万	总股本108.44万
成交额11.81万	换手率1.77%	流通股本105.55万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"SILO","market":"US","secType":"STK","nameCN":"SILO PHARMA INC.","latestPrice":6.46,"timestamp":1781035200000,"preClose":6.26,"halted":0,"volume":18635,"hourTrading":{"tag":"盘后","latestPrice":6.6085,"preClose":6.46,"latestTime":"17:23 EDT","volume":1919,"amount":12654.171163399998,"timestamp":1781040233615,"change":0.1485,"changeRate":0.022988,"amplitude":0.086687},"delay":0,"changeRate":0.03194888178913741,"floatShares":1055526,"shares":1084440,"eps":-6.7971,"marketStatus":"盘后交易","change":0.2,"latestTime":"06-09 17:29:06 EDT","open":6.21,"high":6.7,"low":6.12,"amount":118111.9153505,"amplitude":0.092652,"askPrice":6.98,"askSize":1,"bidPrice":6.59,"bidSize":94,"shortable":3,"etf":0,"ttmEps":-6.7971,"tradingStatus":3,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1781049600000},"marketStatusCode":4,"adr":0,"exchange":"NASDAQ","adjPreClose":6.26,"preHourTrading":{"tag":"盘前","latestPrice":6.23,"preClose":6.26,"latestTime":"09:29 EDT","volume":15,"amount":93.5500005,"timestamp":1781011799070,"change":-0.03,"changeRate":-0.004792,"amplitude":0.001597},"postHourTrading":{"tag":"盘后","latestPrice":6.6085,"preClose":6.46,"latestTime":"17:23 EDT","volume":1919,"amount":12654.171163399998,"timestamp":1781040233615,"change":0.1485,"changeRate":0.022988,"amplitude":0.086687},"volumeRatio":0.348447},"requestUrl":"/m/hq/s/SILO/tweets","defaultTab":"tweets","newsList":[{"id":"1117737017","title":"Silo Pharma旗下Demerx NB获FDA新药临床试验批准 诺伊波加因靶向酒精使用障碍治疗","url":"https://stock-news.laohu8.com/highlight/detail?id=1117737017","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1117737017?lang=zh_cn&edition=full","pubTime":"2026-04-29 21:09","pubTimestamp":1777468162,"startTime":"0","endTime":"0","summary":"生物制药公司Silo Pharma Inc.宣布，其研发的Demerx NB新药已获得美国食品药品监督管理局（FDA）的新药临床试验（IND）批准。该药物以诺伊波加因（Noribogaine）为核心活性成分，旨在开发用于治疗酒精使用障碍（AUD）的新型疗法。\n此次IND获批标志着该候选药物正式获准进入人体临床研究阶段，为推进其治疗酒精依赖的潜力迈出关键一步。公司表示将按计划开展后续临床试验，以评估Demerx NB的安全性与有效性。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SILO","BK4202","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1150576656","title":"Silo制药公司战略性收购Qwikagents平台 进军千亿美元AI代理市场","url":"https://stock-news.laohu8.com/highlight/detail?id=1150576656","media":"美股速递","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1150576656?lang=zh_cn&edition=full","pubTime":"2026-04-23 04:16","pubTimestamp":1776888982,"startTime":"0","endTime":"0","summary":"Silo制药公司宣布通过收购托管式AI代理平台Qwikagents，正式启动向价值数十亿美元的AI代理市场的战略性业务扩张。这一重大举措标志着公司从传统制药领域向人工智能技术领域的战略转型。\n此次收购将使Silo制药公司快速获得成熟的AI代理技术平台，立即进入快速增长的人工智能代理市场。Qwikagents平台作为托管式AI代理解决方案，在自动化业务流程和智能决策支持领域具有显著技术优势。\n市场分析师指出，AI代理市场预计将在未来几年呈现指数级增长，此次战略性收购为Silo制药公司提供了抢占市场先机的宝贵机会。公司表示，这一举措将有效拓展其业务范围，创造新的收入增长点。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4202","SILO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2614031743","title":"Silo Pharma, Inc.盘中异动 早盘急速下跌9.66%报0.315美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2614031743","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614031743?lang=zh_cn&edition=full","pubTime":"2026-02-25 22:31","pubTimestamp":1772029862,"startTime":"0","endTime":"0","summary":"北京时间2026年02月25日22时31分，Silo Pharma, Inc.股票出现波动，股价急速下挫9.66%。Silo Pharma, Inc.股票所在的生物技术行业中，整体跌幅为0.20%。Silo Pharma, Inc.公司简介：SILO Pharma Inc是一家处于发展阶段的生物制药公司，开发新型疗法，用于治疗治疗不足的疾病，包括压力引起的精神疾病、慢性疼痛疾病和中枢神经系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260225223102a4c7a676&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260225223102a4c7a676&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SILO","BK4139","CNS","BK4135","BK4202"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1172301305","title":"Silo Pharma与Allucent签署意向书 推进SPC-15一期临床开发","url":"https://stock-news.laohu8.com/highlight/detail?id=1172301305","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1172301305?lang=zh_cn&edition=full","pubTime":"2025-12-30 21:12","pubTimestamp":1767100346,"startTime":"0","endTime":"0","summary":"Silo Pharma已正式与全球临床研究机构Allucent达成合作意向，双方签署具有战略意义的意向书，旨在加速其创新药物SPC-15的一期临床试验进程。这一关键举措标志着该药物从临床前研究迈向人体试验的重要转折，为后续治疗方案的开发奠定基础。通过整合Allucent在临床试验设计与管理领域的专业资源，Silo Pharma将系统评估SPC-15的安全性与耐受性，推动其神经精神疾病治疗管线的实质性进展。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4202","BK4139","SILO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2593682434","title":"Silo Pharma, Inc.盘中异动 股价大涨8.51%","url":"https://stock-news.laohu8.com/highlight/detail?id=2593682434","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593682434?lang=zh_cn&edition=full","pubTime":"2025-12-23 05:00","pubTimestamp":1766437200,"startTime":"0","endTime":"0","summary":"北京时间2025年12月23日05时00分，Silo Pharma, Inc.股票出现波动，股价大幅上涨8.51%。Silo Pharma, Inc.股票所在的生物技术行业中，整体涨幅为0.83%。Silo Pharma, Inc.公司简介：SILO Pharma Inc是一家处于发展阶段的生物制药公司，开发新型疗法，用于治疗治疗不足的疾病，包括压力引起的精神疾病、慢性疼痛疾病和中枢神经系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251223050001a46bc7a7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251223050001a46bc7a7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4135","SILO","BK4139","CNS","BK4202"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2516580686","title":"Silo Pharma, Inc.盘中异动 股价大跌5.46%报1.28美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516580686","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516580686?lang=zh_cn&edition=full","pubTime":"2025-03-03 23:52","pubTimestamp":1741017146,"startTime":"0","endTime":"0","summary":"北京时间2025年03月03日23时52分，Silo Pharma, Inc.股票出现异动，股价大幅跳水5.46%。截至发稿，该股报1.28美元/股，成交量2.1069万股，换手率0.47%，振幅4.43%。Silo Pharma, Inc.股票所在的生物技术行业中，整体跌幅为0.34%。Silo Pharma, Inc.公司简介：SILO Pharma Inc是一家处于发展阶段的生物制药公司，开发新型疗法，用于治疗治疗不足的疾病，包括压力引起的精神疾病、慢性疼痛疾病和中枢神经系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303235227989a244e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303235227989a244e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CNS","SILO","BK4135","BK4202"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514438101","title":"Silo Pharma, Inc.盘中异动 股价大跌5.67%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514438101","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514438101?lang=zh_cn&edition=full","pubTime":"2025-02-27 23:44","pubTimestamp":1740671073,"startTime":"0","endTime":"0","summary":"北京时间2025年02月27日23时44分，Silo Pharma, Inc.股票出现异动，股价大幅跳水5.67%。Silo Pharma, Inc.股票所在的生物技术行业中，整体涨幅为0.85%。Silo Pharma, Inc.公司简介：SILO Pharma Inc是一家处于发展阶段的生物制药公司，开发新型疗法，用于治疗治疗不足的疾病，包括压力引起的精神疾病、慢性疼痛疾病和中枢神经系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250227234433abdf8164&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250227234433abdf8164&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4202","CNS","BK4135","SILO","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514086930","title":"Silo Pharma, Inc.盘中异动 快速上涨5.40%报1.47美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514086930","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514086930?lang=zh_cn&edition=full","pubTime":"2025-02-27 02:30","pubTimestamp":1740594617,"startTime":"0","endTime":"0","summary":"北京时间2025年02月27日02时30分，Silo Pharma, Inc.股票出现波动，股价急速拉升5.40%。Silo Pharma, Inc.股票所在的生物技术行业中，整体跌幅为0.56%。Silo Pharma, Inc.公司简介：SILO Pharma Inc是一家处于发展阶段的生物制药公司，开发新型疗法，用于治疗治疗不足的疾病，包括压力引起的精神疾病、慢性疼痛疾病和中枢神经系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022702301896317b61&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022702301896317b61&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4202","CNS","SILO","BK4135"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514604186","title":"Silo Pharma, Inc.盘中异动 急速拉升5.56%报1.38美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514604186","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514604186?lang=zh_cn&edition=full","pubTime":"2025-02-26 04:58","pubTimestamp":1740517098,"startTime":"0","endTime":"0","summary":"北京时间2025年02月26日04时58分，Silo Pharma, Inc.股票出现异动，股价急速拉升5.56%。Silo Pharma, Inc.股票所在的生物技术行业中，整体涨幅为0.16%。Silo Pharma, Inc.公司简介：SILO Pharma Inc是一家处于发展阶段的生物制药公司，开发新型疗法，用于治疗治疗不足的疾病，包括压力引起的精神疾病、慢性疼痛疾病和中枢神经系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502260458189892928d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502260458189892928d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CNS","BK4202","BK4135","SILO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2513727576","title":"Silo Pharma, Inc.盘中异动 早盘股价大跌5.19%报1.28美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2513727576","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2513727576?lang=zh_cn&edition=full","pubTime":"2025-02-24 22:48","pubTimestamp":1740408534,"startTime":"0","endTime":"0","summary":"北京时间2025年02月24日22时48分，Silo Pharma, Inc.股票出现异动，股价急速下跌5.19%。Silo Pharma, Inc.股票所在的生物技术行业中，整体跌幅为0.02%。Silo Pharma, Inc.公司简介：SILO Pharma Inc是一家处于发展阶段的生物制药公司，开发新型疗法，用于治疗治疗不足的疾病，包括压力引起的精神疾病、慢性疼痛疾病和中枢神经系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502242248549890fa1f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502242248549890fa1f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CNS","BK4202","BK4135","SILO","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2513153612","title":"Silo Pharma, Inc.盘中异动 下午盘急速下跌5.03%报1.42美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2513153612","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2513153612?lang=zh_cn&edition=full","pubTime":"2025-02-22 02:02","pubTimestamp":1740160928,"startTime":"0","endTime":"0","summary":"北京时间2025年02月22日02时02分，Silo Pharma, Inc.股票出现波动，股价急速跳水5.03%。Silo Pharma, Inc.股票所在的生物技术行业中，整体涨幅为0.34%。Silo Pharma, Inc.公司简介：SILO Pharma Inc是一家处于发展阶段的生物制药公司，开发新型疗法，用于治疗治疗不足的疾病，包括压力引起的精神疾病、慢性疼痛疾病和中枢神经系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250222020209962baaa3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250222020209962baaa3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4135","CNS","SILO","BK4202"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2512806564","title":"Silo Pharma, Inc.盘中异动 快速拉升5.00%报1.47美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2512806564","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512806564?lang=zh_cn&edition=full","pubTime":"2025-02-20 01:35","pubTimestamp":1739986535,"startTime":"0","endTime":"0","summary":"北京时间2025年02月20日01时35分，Silo Pharma, Inc.股票出现波动，股价快速拉升5.00%。Silo Pharma, Inc.股票所在的生物技术行业中，整体涨幅为0.42%。Silo Pharma, Inc.公司简介：SILO Pharma Inc是一家处于发展阶段的生物制药公司，开发新型疗法，用于治疗治疗不足的疾病，包括压力引起的精神疾病、慢性疼痛疾病和中枢神经系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502200135369628eb12&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502200135369628eb12&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4135","SILO","BK4202","CNS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2510684380","title":"Silo Pharma, Inc.盘中异动 早盘大幅下跌5.19%","url":"https://stock-news.laohu8.com/highlight/detail?id=2510684380","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2510684380?lang=zh_cn&edition=full","pubTime":"2025-02-11 22:43","pubTimestamp":1739285014,"startTime":"0","endTime":"0","summary":"北京时间2025年02月11日22时43分，Silo Pharma, Inc.股票出现异动，股价急速下跌5.19%。Silo Pharma, Inc.股票所在的生物技术行业中，整体跌幅为1.36%。Silo Pharma, Inc.公司简介：SILO Pharma Inc是一家处于发展阶段的生物制药公司，开发新型疗法，用于治疗治疗不足的疾病，包括压力引起的精神疾病、慢性疼痛疾病和中枢神经系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250211224334961f4a0f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250211224334961f4a0f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SILO","OCEA","CNS","BK4139","BK4135","BK4202"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2509272485","title":"Silo Pharma, Inc.盘中异动 早盘快速拉升5.68%报1.82美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2509272485","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2509272485?lang=zh_cn&edition=full","pubTime":"2025-02-06 22:42","pubTimestamp":1738852920,"startTime":"0","endTime":"0","summary":"北京时间2025年02月06日22时42分，Silo Pharma, Inc.股票出现波动，股价快速上涨5.68%。Silo Pharma, Inc.股票所在的生物技术行业中，整体跌幅为0.07%。Silo Pharma, Inc.公司简介：SILO Pharma Inc是一家处于发展阶段的生物制药公司，开发新型疗法，用于治疗治疗不足的疾病，包括压力引起的精神疾病、慢性疼痛疾病和中枢神经系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250206224201a23bd0d9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250206224201a23bd0d9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CNS","BK4135","SILO","BK4202","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2508572594","title":"Silo Pharma, Inc.盘中异动 股价大跌5.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2508572594","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2508572594?lang=zh_cn&edition=full","pubTime":"2025-02-04 22:31","pubTimestamp":1738679489,"startTime":"0","endTime":"0","summary":"北京时间2025年02月04日22时31分，Silo Pharma, Inc.股票出现异动，股价大幅下挫5.02%。Silo Pharma, Inc.股票所在的生物技术行业中，整体跌幅为0.58%。Silo Pharma, Inc.公司简介：SILO Pharma Inc是一家处于发展阶段的生物制药公司，开发新型疗法，用于治疗治疗不足的疾病，包括压力引起的精神疾病、慢性疼痛疾病和中枢神经系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502042231299617d782&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502042231299617d782&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CNS","SILO","BK4135","BK4202","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2508418381","title":"Silo Pharma, Inc.盘中异动 大幅上涨11.19%报1.79美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2508418381","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2508418381?lang=zh_cn&edition=full","pubTime":"2025-02-03 22:35","pubTimestamp":1738593321,"startTime":"0","endTime":"0","summary":"北京时间2025年02月03日22时35分，Silo Pharma, Inc.股票出现波动，股价大幅上涨11.19%。Silo Pharma, Inc.股票所在的生物技术行业中，整体跌幅为0.36%。Silo Pharma, Inc.公司简介：SILO Pharma Inc是一家处于发展阶段的生物制药公司，开发新型疗法，用于治疗治疗不足的疾病，包括压力引起的精神疾病、慢性疼痛疾病和中枢神经系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250203223521abc107f2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250203223521abc107f2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SILO","BK4139","BK4135","BK4202","CNS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2508696042","title":"Silo Pharma, Inc.盘中异动 大幅跳水5.46%","url":"https://stock-news.laohu8.com/highlight/detail?id=2508696042","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2508696042?lang=zh_cn&edition=full","pubTime":"2025-02-01 00:55","pubTimestamp":1738342510,"startTime":"0","endTime":"0","summary":"北京时间2025年02月01日00时55分，Silo Pharma, Inc.股票出现异动，股价大幅跳水5.46%。Silo Pharma, Inc.股票所在的生物技术行业中，整体涨幅为1.56%。Silo Pharma, Inc.公司简介：SILO Pharma Inc是一家处于发展阶段的生物制药公司，开发新型疗法，用于治疗治疗不足的疾病，包括压力引起的精神疾病、慢性疼痛疾病和中枢神经系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025020100551098777086&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025020100551098777086&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4202","BK4135","CNS","SILO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2506454586","title":"Silo Pharma, Inc.盘中异动 下午盘大幅下跌5.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2506454586","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2506454586?lang=zh_cn&edition=full","pubTime":"2025-01-28 02:39","pubTimestamp":1738003147,"startTime":"0","endTime":"0","summary":"北京时间2025年01月28日02时39分，Silo Pharma, Inc.股票出现波动，股价急速跳水5.07%。Silo Pharma, Inc.股票所在的生物技术行业中，整体涨幅为0.81%。Silo Pharma, Inc.公司简介：SILO Pharma Inc是一家处于发展阶段的生物制药公司，开发新型疗法，用于治疗治疗不足的疾病，包括压力引起的精神疾病、慢性疼痛疾病和中枢神经系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025012802390796125e17&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025012802390796125e17&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SILO","CNS","BK4139","BK4135","BK4202"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2505477864","title":"Silo Pharma, Inc.盘中异动 股价大涨5.61%","url":"https://stock-news.laohu8.com/highlight/detail?id=2505477864","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2505477864?lang=zh_cn&edition=full","pubTime":"2025-01-24 23:13","pubTimestamp":1737731614,"startTime":"0","endTime":"0","summary":"北京时间2025年01月24日23时13分，Silo Pharma, Inc.股票出现波动，股价大幅上涨5.61%。Silo Pharma, Inc.股票所在的生物技术行业中，整体跌幅为0.64%。Silo Pharma, Inc.公司简介：SILO Pharma Inc是一家处于发展阶段的生物制药公司，开发新型疗法，用于治疗治疗不足的疾病，包括压力引起的精神疾病、慢性疼痛疾病和中枢神经系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250124231335a22e63ec&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250124231335a22e63ec&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4135","BK4139","BK4202","CNS","SILO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2505802836","title":"Silo Pharma, Inc.盘中异动 急速拉升5.35%","url":"https://stock-news.laohu8.com/highlight/detail?id=2505802836","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2505802836?lang=zh_cn&edition=full","pubTime":"2025-01-24 03:40","pubTimestamp":1737661225,"startTime":"0","endTime":"0","summary":"北京时间2025年01月24日03时40分，Silo Pharma, Inc.股票出现异动，股价快速拉升5.35%。Silo Pharma, Inc.股票所在的生物技术行业中，整体涨幅为1.23%。Silo Pharma, Inc.公司简介：SILO Pharma Inc是一家处于发展阶段的生物制药公司，开发新型疗法，用于治疗治疗不足的疾病，包括压力引起的精神疾病、慢性疼痛疾病和中枢神经系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250124034026abb636bb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250124034026abb636bb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CNS","BK4135","SILO","BK4202","BK4139"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.silopharma.com","stockEarnings":[{"period":"1week","weight":0.2548},{"period":"1month","weight":0.0305},{"period":"3month","weight":0.2034},{"period":"6month","weight":-0.0515},{"period":"1year","weight":-0.2818},{"period":"ytd","weight":0.2275}],"compareEarnings":[{"period":"1week","weight":-0.0255},{"period":"1month","weight":0.0022},{"period":"3month","weight":0.0916},{"period":"6month","weight":0.0751},{"period":"1year","weight":0.2338},{"period":"ytd","weight":0.084}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Silo Pharma, Inc.于2010年7月13日在纽约州注册成立。2013年1月24日，公司将其注册地从纽约州改为特拉华州。2023年12月19日，该公司将其注册州从特拉华州改为内华达州。该公司是一家处于开发阶段的生物制药和加密货币公司，专注于开发针对创伤后应激障碍、应激性焦虑症、纤维肌痛和中枢神经系统疾病等未满足需求的新型疗法。其主要项目SPC-15是一种用于治疗创伤后应激障碍和应激性焦虑症的鼻内候选药物。","yearOnYearQuotes":[{"month":1,"riseRate":0.666667,"avgChangeRate":0.152367},{"month":2,"riseRate":0.333333,"avgChangeRate":-0.066329},{"month":3,"riseRate":0.333333,"avgChangeRate":0.008428},{"month":4,"riseRate":0.333333,"avgChangeRate":-0.080378},{"month":5,"riseRate":0.333333,"avgChangeRate":-0.077056},{"month":6,"riseRate":0.333333,"avgChangeRate":-0.068382},{"month":7,"riseRate":0.8,"avgChangeRate":0.245522},{"month":8,"riseRate":0.2,"avgChangeRate":-0.147776},{"month":9,"riseRate":0.6,"avgChangeRate":8.06309},{"month":10,"riseRate":0.333333,"avgChangeRate":-0.161821},{"month":11,"riseRate":0.333333,"avgChangeRate":0.075379},{"month":12,"riseRate":0.166667,"avgChangeRate":-0.093022}],"exchange":"NASDAQ","name":"SILO PHARMA INC.","nameEN":"SILO PHARMA INC."},"APP":{"userAgent":"CCBot/2.0 (https://commoncrawl.org/faq/)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.43.1","shortVersion":"4.43.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"SILO PHARMA INC.(SILO)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供SILO PHARMA INC.(SILO)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"SILO PHARMA INC.,SILO,SILO PHARMA INC.股票,SILO PHARMA INC.股票老虎,SILO PHARMA INC.股票老虎国际,SILO PHARMA INC.行情,SILO PHARMA INC.股票行情,SILO PHARMA INC.股价,SILO PHARMA INC.股市,SILO PHARMA INC.股票价格,SILO PHARMA INC.股票交易,SILO PHARMA INC.股票购买,SILO PHARMA INC.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"SILO PHARMA INC.(SILO)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供SILO PHARMA INC.(SILO)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}